OBJECTIVE: The primary endpoint of this trial was to assess clinical response (cCR) of squamocellular vulvar cancer (V-SCC) in elderly patients treated with electro-chemotherapy (ECT). Secondary endpoints were symptoms relief and local tumor control. METHODS: A phase II study was designed and elderly patients with V-SCC unfit for other treatments were treated. Response Evaluation Criteria in Solid Tumors (RECIST criteria) were applied to evaluate tumor response. Quality of life (QoL) was evaluated by visual analogue score (VAS) for pain and four items of vulvar cancer subscale (VCS), of functional assessment of vulvar cancer therapy (FACT-V) [16], before, one month after the procedure and during follow-up. RESULTS: Median age was 85 years (range 66-96 years). One month after treatment complete response was observed in 13 patients (52%), partial response in 7 (28%), stable disease in 3 (12%), and progressive disease in 2 (8%). Local tumor control at 1 and 6 months was 91% and 53%, respectively. Symptom free survival at 1 and 6 months was 78% and 40%, respectively, with significant reduction of pain (P < 0.01). One-year overall survival was 34%. CONCLUSIONS: Our study showed that ECT produces high response rate with significant reduction of pain and improvement of local symptoms.

Perrone, A.M., Cima, S., Pozzati, F., Frakulli, R., Cammelli, S., Tesei, M., et al. (2015). Palliative electro-chemotherapy in elderly patients with vulvar cancer: A phase II trial. JOURNAL OF SURGICAL ONCOLOGY, 112(5), 529-532 [10.1002/jso.24036].

Palliative electro-chemotherapy in elderly patients with vulvar cancer: A phase II trial

PERRONE, ANNA MYRIAM;CIMA, SIMONA;POZZATI, FEDERICA;FRAKULLI, REZARTA;CAMMELLI, SILVIA;GASPARRE, GIUSEPPE;MORGANTI, ALESSIO GIUSEPPE;DE IACO, PIERANDREA
2015

Abstract

OBJECTIVE: The primary endpoint of this trial was to assess clinical response (cCR) of squamocellular vulvar cancer (V-SCC) in elderly patients treated with electro-chemotherapy (ECT). Secondary endpoints were symptoms relief and local tumor control. METHODS: A phase II study was designed and elderly patients with V-SCC unfit for other treatments were treated. Response Evaluation Criteria in Solid Tumors (RECIST criteria) were applied to evaluate tumor response. Quality of life (QoL) was evaluated by visual analogue score (VAS) for pain and four items of vulvar cancer subscale (VCS), of functional assessment of vulvar cancer therapy (FACT-V) [16], before, one month after the procedure and during follow-up. RESULTS: Median age was 85 years (range 66-96 years). One month after treatment complete response was observed in 13 patients (52%), partial response in 7 (28%), stable disease in 3 (12%), and progressive disease in 2 (8%). Local tumor control at 1 and 6 months was 91% and 53%, respectively. Symptom free survival at 1 and 6 months was 78% and 40%, respectively, with significant reduction of pain (P < 0.01). One-year overall survival was 34%. CONCLUSIONS: Our study showed that ECT produces high response rate with significant reduction of pain and improvement of local symptoms.
2015
Perrone, A.M., Cima, S., Pozzati, F., Frakulli, R., Cammelli, S., Tesei, M., et al. (2015). Palliative electro-chemotherapy in elderly patients with vulvar cancer: A phase II trial. JOURNAL OF SURGICAL ONCOLOGY, 112(5), 529-532 [10.1002/jso.24036].
Perrone, Anna M; Cima, Simona; Pozzati, Federica; Frakulli, Rezarta; Cammelli, Silvia; Tesei, Marco; Gasparre, Giuseppe; Galuppi, Andrea; Morganti, Al...espandi
File in questo prodotto:
Eventuali allegati, non sono esposti

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/520441
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 7
  • Scopus 24
  • ???jsp.display-item.citation.isi??? 23
social impact